Pursuant to the provisions of Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, we would like to inform you that at the meeting of Board of ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Phyto Chem (India) Limited met on 14 February 2026 and approved the Unaudited Financial Results for the third quarter and nine months ended 31 December 2025. The meeting lasted from 4:00 PM to 5:30 PM. The company has informed BSE of this outcome as required under SEBI's Listing Regulations. No specific financial figures, growth metrics, or other items were disclosed in this filing beyond the routine approval of quarterly results.
This is a routine regulatory filing confirming the Board approved Q3 FY26 results. No material new information for shareholders is contained in this notice; investors should await the detailed financial results for actual performance insights.